https://www.selleckchem.com/products/ABT-263.html
To evaluate the efficacy and safety of adjunct dapagliflozin therapy in patients with type 1 diabetes (T1D). DEPICT-1 and -2 were randomized, double-blind, parallel-group, 24-week studies, with 28-week extension periods. Adults with T1D and HbA1c 7.5%-10.5% were randomized (111) to receive dapagliflozin 5 mg, 10 mg or placebo. The short- and long-term efficacy and safety of dapagliflozin were examined in an exploratory pooled analysis of both studies. Efficacy analyses included 530, 529 and 532 and safety analysis included 548, 566 and

https://www.selleckchem.com/pr....oducts/pentetic-acid
156) were higher in the Dollar arm than the Control group, while loss-to-follow-up was lower in the Dollar arm (10.0% vs. 20.8% p = 0.07. Participants in the Dollar arm were more likely to be cured (adjusted incidence rate ratio (aIRR) 1.59, 95% CI 1.04-2.44, p = 0.032) and less likely to be lost to follow-up (aIRR 0.44, 95% CI 0.20-0.96, p = 0.04. A one-dollar incentive was associated with higher TB cure and lower loss-to-follow-up among people with TB in rural Uganda.Fibrosis is characterized by the excessive production of c